株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

成体幹細胞市場動向:2011年

Adult Stem Cells Market Trends 2011

発行 SELECTBIO, Ltd. 商品コード 144377
出版日 ページ情報 英文 100 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
成体幹細胞市場動向:2011年 Adult Stem Cells Market Trends 2011
出版日: 2011年01月20日 ページ情報: 英文 100 Pages
概要

当レポートでは、成体幹細胞市場の最新動向を分析し、現在の細胞療法の概要と現在実施されている内容、治験パイプライン動向などをまとめ、幹細胞研究の商業的動向も交え、概略下記の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 間充織幹細胞(MSC)とその治療可能性

  • 成体幹細胞:HSCおよびMSC(短期的細胞療法)
  • MSCの特性
  • MSCを特徴付けるマーカー
  • MSCの多能性
  • MSCによる組織修復の機序

第3章 臍帯血幹細胞とその治療可能性

  • 造血幹細胞移植における臍帯血
  • 臍帯血による移植効率
  • 小児および成人レシピエントの移植動向
  • 臍帯血移植と骨髄移植との比較
  • 世界市場規模と成長率
  • 国別公的臍帯血バンキング

第4章 成体幹細胞研究と商品化

  • 市場セグメンテーションと業界構造
  • 成体幹細胞市場予測とタイムライン
  • 自家および同種幹細胞の定量的市場セグメンテーション
  • 2011年:セグメント別幹細胞市場予測
  • 幹細胞市場調査による現在の研究動向
  • 幹細胞分野における出版動向
  • 認可済み細胞療法製品、治験、細胞療法の定量的市場動向

付録:調査方法

目次

This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics.

This report details the current status of the cellular therapeutics marketplace, products that are commercialized, market potential, clinical trials pipeline and characterization of this pipeline by therapeutic class. The report also provides an analysis of the cellular therapeutics that are currently performed and categorizes them according to type/class of adult stem cell utilized as well as disease(s) treated.

This report analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease classes treated, size of public cord blood banking, associated growth, as well as market drivers and associated qualitative trends.

This report presents an exhaustive analysis of the commercial trends in stem cell research by describing the quantitative metrics (market size, growth rate, segmentation), as well as data from primary market surveys describing trends in stem cell research from the bottom-up. These data are derived from Select Biosciences worldwide pool of researchers and therefore provide invaluable insight into stem cell research trends (both qualitative and quantitative).

This data-driven characterization of the adult stem cells market landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development - all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.

Extensive Worldwide Technical and Market Analyses Presented in this Report:

  • Characterization of Mesenchymal Stem Cells (MSCs)
    • Their biological properties
    • Mechanisms of tissue repair/regenerative function in vivo
  • Characterization of the Cord Blood Stem Cell Marketplace
    • Quantitative utilization for various disease classes
    • Utilization from different patient types (adult versus pediatric)
    • Size of the public cord blood banking space - number of stored cord blood units available for transplantation
    • Growth rate of the public cord blood banking space
    • Distribution of selected cord blood banks by worldwide region
  • Adult Stem Cells Commercialization Quantitative Trends
    • Cellular therapy market opportunity forecast
    • Growth rate
    • Breakout of the cellular therapy market by autologous versus allogeneic usage
    • Analysis of current stem cell clinical trials pipeline - by stage, by disease class/therapeutic area
    • Cellular therapeutic products currently commercialized and their quantitative market penetrance
    • Cellular therapies performed and their breakout by type of adult stem cell, disease class (therapeutic area) addressed
  • Research Trends Analyzed by Bottom-up Worldwide Market Survey
    • Describes market segmentation by stem cell class
    • Utilization of different cell types for research in cellular therapy
    • Utilization of different cell types for drug discovery/development/toxicity screening assays
    • Types of assays for drug discovery/development/toxicity screening that are deployed using stem cells currently - assay class, market forecast
    • Markers used to characterize different stem cell types (pluripotent stem cells, MSCs, NSCs, HSCs)
    • Market penetrance of different vendors into the overall stem cell marketplace - by reagent class
    • Differentiation of different stem cell types into various cellular lineages
  • More details of the scope of coverage of this industry report are found in the Table of Contents (TOC) for the report

Table of Contents

Chapter I. Executive Overview

Chapter II. Mesenchymal Stem Cells (MSCs) and Their Therapeutic Potential

  • Adult Stem Cells - HSCs & MSCs: Cellular Therapeutics in the Near-Term
  • Properties of MSCs
  • Markers that Characterize MSCs
  • Multipotency of MSCs
  • Mechanisms of MSC-Mediated Tissue Repair

Chapter III. Cord Blood-Derived Stem Cells and Their Therapeutic Potential

  • Umbilical Cord Blood in Hematopoietic Stem Cell Transplantation
  • Engrafting Efficiency with Cord Blood
  • Transplant Trends for Pediatric and Adult Recipients: Market Penetrance of Cord Blood
  • Comparison of Cord Blood Transplants vis-a-vis Bone Marrow Transplants
  • Cord Blood Units Worldwide Market Size and Growth Rate
  • Breakout of Public Cord Blood Banking by Country

Chapter IV. Adult Stem Cell Research and Commercialization

  • Market Segmentation and Industry Structure
  • Adult Stem Cell Market Projections and Timeline
  • Autologous versus Allogeneic Quantitative Market Segmentation
  • 2011: Stem Cells Market Forecast by Segment
  • Stem Cell Primary Market Survey Highlighting Current Research Trends (Qualitative and Quantitative Data/Analysis)
  • Publication Trends in the Stem Cells Space
  • Approved Cellular Therapy Products, Clinical Trials, and Cellular Therapy Quantitative Market Trends

Appendix I. Research Methodology

Back to Top